Table 3.

Markers of risk of death or need for mechanical ventilation.

Variables	Death or mechanical ventilation (n = 13)	No death nor mechanical ventilation (n = 27)	P‐value
Age, years	55.8 ± 11.2	53.2 ± 16.7	0.97
Male sex	11 (84.6%)	15 (55.6%)	0.15
Blood type O (vs. other blood types)	4 (30.8%)	10 (37.0%)	0.73
Blood type A (vs. other blood types)	7 (53.8%)	9 (33.3%)	0.21
Pretransplant ischaemic cardiomyopathy	5 (38.5%)	6 (22.2%)	0.28
Time post‐transplantation, years	4.3 (1.4–8.8)	5.0 (1.9–9.0)	0.65
History of acute rejection	8 (61.5%)	17 (63.0%)	0.99
History of ISHLT cardiac allograft vasculopathy 2 or 3	2 (15.4%)	7 (25.9%)	0.69
Cytomegalovirus positive status	10/12 (83.3%)	16/26 (61.5%)	0.28
Epstein Barr Virus positive status	12/12 (100.0%)	23/25 (92%)	0.99
Chronic kidney disease stage III or higher	9 (69.2%)	12 (44.4%)	0.31
Diabetes mellitus	7 (53.8%)	9 (33.3%)	0.25
Dyslipidaemia	5 (38.5%)	7 (25.9%)	0.46
Hypertension	9 (69.2%)	19 (70.3%)	0.99
Body mass index, kg/m2	26.3 ± 4.3	27.3 ± 6.2	0.60
Baseline medication
ACE‐I or ARB	7 (53.8%)	9 (33.3%)	0.25
Prednisone dosage >5 mg per day	6 (46.2%)	12 (44.4%)	0.99
Dual immunosuppressive therapy	1 (7.7%)	4 (14.8%)	0.65
CT lung involvement ≥50%	8/12 (66.7%)	3/21 (14.3%)	0.006
Laboratory variables at admission
Creatinine, µmol/l	298.0 (149.0–522.0)	137.0 (97.5–236.5)	0.07
C‐reactive protein, mg/l	75.5 (44.3–182.5)	31.9 (3.0–62.6)	0.01
NT‐proBNP, ng/l	895.0 (429.8–3555.0)	1084.0 (433.5–5847.0)	0.89
White blood cell count, 109/l	6.8 (4.8–11.3)	5.7 (4.0–7.0)	0.16
Lymphocyte count, 109/l	0.53 (0.30–0.84)	0.72 (0.43–1.02)	0.23
Procalcitonin, µg/l	0.80 (0.33–1.00)	0.11 (0.04–0.72)	0.054
Fibrinogen, g/l	5.1 (3.4–7.8)	4.9 (3.8–6.1)	0.82
D‐dimer, ng/ml	1524.0 (1268.0–5308.0)	1156 (340.0–2151.0)	0.22

ISHLT, International Society for Heart and Lung Transplantation.